Can J Vet Res
Department of Veterinary Pathology (Yonpiam, Al-Dissi), Department of Veterinary Biomedical Sciences (Blakley), and Department of Pharmacology (Desai), College of Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4.
Published: October 2024
Ergot alkaloids are known to cause devastating effects in livestock. The objectives of this study were to evaluate the effects of prolonged ergot exposure on selected vasculature in pregnant sheep and to examine the role of -1 adrenergic receptors in mediating these effects. Twelve 60-day pregnant sheep were randomly placed into control and exposure groups ( = 6/group). Ergot-contaminated feed pellets were given orally once a day for 45 d to the exposure group [46.6 μg/kg body weight (BW) total ergot alkaloids]. The control group (Ctl) received ergot-free pellets. The maternal pedal artery from the left hindlimb and the umbilical artery and vein were dissected and mounted in a tissue bath. The vascular contractile response to a cumulatively increasing dose of phenylephrine (PE) in the exposure group (Exp) was compared with the control groups. Chronic exposure to ergot alkaloids resulted in a 70.6% and 91.3% increase in PE contractile response in the umbilical artery (Ctl EC = 3.962 × 10; Exp EC = 1.161 × 10, < 0.0001) and the umbilical vein (Ctl EC = 7.889 × 10; Exp EC = 6.801 × 10, < 0.0001), respectively, but there was no increase in the pedal artery ( = 0.3927), when compared to the control group. Fetal weight in the ergot-exposed group was significantly lower than in the control group (Ctl 3.3 ± 0.17 kg; Exp 2.07 ± 0.13 kg, = 0.0002). The increase in contractile response in the umbilical vein may result in decreased blood supply to the fetus causing decreased fetal weight. Negative impact was seen at significantly lower levels of ergot alkaloids than what is currently allowed by Canadian standards, which suggests that these limits should be reevaluated to ensure livestock safety.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418788 | PMC |
Zhong Nan Da Xue Xue Bao Yi Xue Ban
July 2024
Department of Endocrinology &Metabolism, West China Hospital, Sichuan University, Chengdu 610041.
Cushing's disease is a rare endocrine disorder characterized by hypercortisolism. Chronic elevated cortisol levels can lead to dysfunction or complications in multiple organs of systems, including cardiovascular, glucose, and bone metabolism, severely impacting patients' quality of life and posing life-threatening risks. Surgery is the first-line treatment for Cushing's disease.
View Article and Find Full Text PDFJ Rural Health
January 2025
Drug Use & Behavior Lab, Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, USA.
Background: Recent legislative initiatives in the United States have focused on the medical and legal status of psychedelics, prompting interest in understanding public perceptions of their risks. This study investigates rural-urban differences in the perception of LSD and cannabis risks using national survey data.
Methods: Data from the National Survey of Drug Use and Health (NSDUH) between 2015 and 2021 were analyzed.
Biochem Biophys Res Commun
January 2025
Department of Biotechnology and Department of Integrative Food, Bioscience and Biotechnology (BK21 FOUR), Chonnam National University, Gwangju, 61186, South Korea. Electronic address:
Methylergometrine has widely been used pharmacologically to treat conditions such as pain, addiction, vasoconstriction, migraines, and Parkinson's disease. Despite its side effects, it is used as a therapeutic agent and research material for various diseases based on its natural potential; however, the regulatory effect of its interaction with the nicotinic acetylcholine receptor (nAChR) has not yet been investigated. The α3β4 nAChR is an ion channel essential for neurotransmission within the sympathetic, parasympathetic, and autonomic nervous systems.
View Article and Find Full Text PDFJ Med Case Rep
December 2024
Department of Neurosurgery, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Background: Giant prolactinoma (size > 4 cm) is a rare condition and accounts for less than 1% of pituitary adenomas. In even rarer cases, these lesions may involve craniocervical structures requiring surgical intervention. The present case is the largest reported giant prolactinoma (99 × 72 × 57 mm).
View Article and Find Full Text PDFInt J Mol Sci
November 2024
Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, China.
Prolactinomas are commonly treated with dopamine receptor agonists (DAs), such as bromocriptine (BRC) and cabergoline (CAB). However, 10-30% of patients exhibit resistance to DA therapies. DA resistance is largely associated with reduced dopamine D2 receptor (DRD2) expression, potentially regulated by epigenetic modifications, though the underlying mechanisms are still unclear.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.